Report Categories
View AllRecent Articles
View All
ALEC Q1 2026 Earnings NarrowerThanExpected Loss Surprises No Revenue Yet
PYPD Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances
Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns
MRX Q1 2026 Earnings EPS Beats Estimates by 634 as Stock Declines
MPLX Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Operational Strength
Belden Inc BDC Faces Selling Pressure Tests Key Support Near 102
Revolution Medicines RVMD Slightly Lower as Biotech Stock Consolidates Near Support
ACP Edges Higher in LowVolume Trading Consolidates Near Resistance
BioXcel Therapeutics BTAI Falls Further as Biotech Struggles to Hold Support